PMC:7796052 / 179-434 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"14","span":{"begin":197,"end":207},"obj":"Gene"}],"attributes":[{"id":"A14","pred":"tao:has_database_id","subj":"14","obj":"Gene:3827"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"nisms involved in illness progression to provide a prompt therapeutical response with an adequate use of available drugs, including drug repurposing. Recently, it was suggested that a dysregulated bradykinin signaling can trigger the cytokine storm observ"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T1","span":{"begin":234,"end":248},"obj":"Phenotype"}],"attributes":[{"id":"A1","pred":"hp_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/HP_0033041"}],"text":"nisms involved in illness progression to provide a prompt therapeutical response with an adequate use of available drugs, including drug repurposing. Recently, it was suggested that a dysregulated bradykinin signaling can trigger the cytokine storm observ"}